Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NURECA LTD.

NSE : NURECABSE : 543264ISIN CODE : INE0DSF01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private

BSE247.604.85 (+2 %)

PREV CLOSE ( ) 242.75

OPEN PRICE ( ) 247.60

BID PRICE (QTY) 247.60 (31986)

OFFER PRICE (QTY) 247.60 (7)

VOLUME 922

TODAY'S LOW / HIGH ( )247.60 247.60

52 WK LOW / HIGH ( )198 447

NSE247.294.84 (+2 %)

PREV CLOSE( ) 242.45

OPEN PRICE ( ) 247.29

BID PRICE (QTY) 247.29 (30517)

OFFER PRICE (QTY) 247.00 (266)

VOLUME 114

TODAY'S LOW / HIGH( ) 247.29 247.29

52 WK LOW / HIGH ( )203.62 447.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-11 2016

Management Info

Saurabh Goyal - Chairman Saurabh Goyal - Managing Director

Registered Office

Address Office No. 101, 1st Floor,Udyog Bhavan, Sonawala Lane,Goregaon (East),
Mumbai,
Maharashtra-400063

Phone 0172-5292900

Email cs@nureca.com

Website www.nureca.com

Registrars Details

Alankit Assignments Ltd.

205-208 , Anarkali Complex,Jhandewala Extension,,New Delhi

Listing : BSE, NSE

NEWS

30Apr Nureca expands quick commerce reach wi
Nureca has made available its flagship brand Dr Trust on Swiggy Instamar..

22Apr Nureca gets nod to set up new manufact
Nureca has received formal approval from the Government of Punjab, Depar..

22Apr Nureca gains on getting nod to set up
Nureca is currently trading at Rs. 250.00, up by 2.55 points or 1.03% fr..

14Apr Nureca’s manufacturing arm completes a
Nureca’s manufacturing subsidiary -- Nureca Technologies has successfull..

12Apr Nureca informs about press release
Nureca has informed that its manufacturing subsidiary successfully compl..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	20.7200000000001	-6.68000000000007
Gross Profit	14.9800000000001	-4.60000000000007
Operating Profit	25.6700000000001	28.0799999999999
Net Sales	317.5	1146.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Laxmi Denta (BSE) 388.10 (5.05%)	M.Cap ( in Cr)2133.08
Prevest Denpro (BSE) 484.00 (2.55%)	M.Cap ( in Cr)580.95
GKB Ophthalmics (BSE) 68.97 (5.90%)	M.Cap ( in Cr)34.76
Hemant Surgical Inds (BSE) 100.00 (2.56%)	M.Cap ( in Cr)104.40
Shree Pacetronix (BSE) 69.74 (0.49%)	M.Cap ( in Cr)25.10

Shareholding Pattern

	PROMOTERS	64.3%
	NON-INSTITUTION	34.62%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

NURECA LTD.